Skip to main content
. Author manuscript; available in PMC: 2012 May 21.
Published in final edited form as: Anticancer Agents Med Chem. 2011 Feb;11(2):202–212. doi: 10.2174/187152011795255957

Fig. (4).

Fig. (4)

Survival curves: Effect of MnTnHex-2-PyP5+ treatment on the survival of mice bearing intracranial human glioblastoma multiforme D-256 MG xenografts. MnTnHex-2-PyP5+ was given sc at a dose of 1.6 mg/kg b.i.d. throughout the duration of experiment.